Trial Profile
A phase II trial of verubulin compared with temozolomide and verubulin plus temozolomide in patients with brain metastases arising from non-small cell lung cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Sep 2011
Price :
$35
*
At a glance
- Drugs Verubulin (Primary) ; Temozolomide
- Indications Cancer metastases; Non-small cell lung cancer
- Focus Therapeutic Use
- 21 Sep 2011 Status changed from recruiting to completed.
- 06 Sep 2007 New trial record.